The Division of Genomics and Bioinformatics drives innovation in cancer research by combining advanced genomic technologies with powerful computational approaches.

Our goal is to understand the molecular and genetic foundations of cancer to improve diagnosis, treatment, and prevention.

Through sequencing, transcriptomic analysis, and integrated bioinformatics, our researchers explore the genetic alterations that drive tumor development and progression. Using data-driven insights and predictive modeling, the division supports precision oncology initiatives aimed at delivering personalized and effective cancer care.

Collaborating closely with clinical and translational teams, the Division of Genomics and Bioinformatics transforms complex genomic data into meaningful discoveries that advance the fight against cancer.